SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-216977
Filing Date
2020-08-12
Accepted
2020-08-12 06:56:52
Documents
2
Effectiveness Date
2020-08-12

Document Format Files

Seq Description Document Type Size
1 DEFA14A d40650ddefa14a.htm DEFA14A 715603
2 GRAPHIC g40650111.jpg GRAPHIC 10385
  Complete submission text file 0001193125-20-216977.txt   731100
Mailing Address 209 PERRY PARKWAY SUITE 13 GAITHERSBURG MD 20877
Business Address 209 PERRY PARKWAY SUITE 13 GAITHERSBURG MD 20877 (301) 825 5320
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36498 | Film No.: 201094049
SIC: 2836 Biological Products, (No Diagnostic Substances)